Cluster Health & Mission Cancer Brokerage Event

28 Sept 2026 | Brussels, Belgium

THERIOPHARM

Company (SME)

www.linkedin.com/in/dr-ing-raphaël-duval-2763a4153Wavre, Belgium
11 profile visits

About

  • nanomedicine platforms

  • drug deliverys systems

  • molecular encapsulation

  • drug repurposing

  • drug combination

  • prebiotics

Representatives

CEO

THERIOPHARM

Marketplace (1)

  • Project cooperation

    NANOCOMBO project: exploring opportunities in drug repurposing associated with multi-drug combination

    We have technologies enabling drug combination in a single nanodrop. Validation made on preclinical murine sepsis model on multi-pan resistant Acinetobacter baumannii multi-pan-resistant to antibiotics.

    • Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
    • Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
    • Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
    • Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
    • Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
    Author

    CEO at THERIOPHARM